SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Europe Alzheimer's Disease Drug Pipeline Analysis

[January 06, 2014]

Research and Markets: Europe Alzheimer's Disease Drug Pipeline Analysis

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/m3tsdp/europe) has announced the addition of the "Europe Alzheimer's Disease Drug Pipeline Analysis" report to their offering.

The incidence of Alzheimer's disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer's disease.

The rapid growth in the prevalence of Alzheimer's disease over the next few decades in Europe is expected to result in immense pressure on the social and health-care systems of the region. There is an urgent need for developing curative or disease-modifying therapies to offset the upcoming Alzheimer's disease epidemic.

Europe Alzheimer's Drug Pipeline Analysis - gives comprehensive insight on the various drugs being developed for the treatment of Alzheimer disease. Research report covers all the ongoing drugs being developed in various development phases.

This report enables phamaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Alzheimer drug market based upon development process.


Following parameters for each drug profile in development phase are covered in - Europe Alzheimer's Drug Pipeline Analysis - research report:

- Drug Profile Overview

- Alternate Names for Drug

- Active Indication

- Phase of Development

- Mechanism of Action

- Brand Name

- Patent Information

- Country for Clinical Trial

- Owner / Originator/ Licensee/Collaborator

- Administrative Route

- Drug Class

- ATC Codes

Europe Alzheimer's Disease Drug Pipeline by Clinical Phase:

- Research: 19

- Preclinical: 49

- Clinical: 1

- Phase-I: 25

- Phase-I/II: 2

- Phase-II: 26

- Phase-II/III: 2

- Phase-III: 5

- Preregistration: 2

- Marketed: 10

- Unknown: 1

Key Topics Covered:

1. Europe Alzheimer's Disease Market Overview

2. Alzheimer's Disease Drug Clinical Phase: Unknown

3. Alzheimer's Disease Drug Clinical Phase: Research

4. Alzheimer's Disease Drug Clinical Phase: Preclinical

5. Alzheimer's Disease Drug Clinical Phase: Clinical

6. Alzheimer's Disease Drug Clinical Phase: Phase-I

7. Alzheimer's Disease Drug Clinical Phase: Phase-I/II

8. Alzheimer's Disease Drug Clinical Phase: Phase-II

9. Alzheimer's Disease Drug Clinical Phase: Phase-II/III

10. Alzheimer's Disease Drug Clinical Phase: Phase-III

11. Alzheimer's Disease Drug Clinical Phase: Preregistration

12. Marketed

List of Tables

For more information visit http://www.researchandmarkets.com/research/m3tsdp/europe

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.